# The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months

> **NCT00006279** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 75 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Nevirapine

## Key facts

- **NCT ID:** NCT00006279
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 75 (—)
- **Last updated:** 2021-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006279, "The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT00006279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*